Pharmadrug Inc.
PHRX
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 52.00K | 52.20K | 94.80K | 109.30K | 161.20K |
| Total Receivables | 6.40K | 16.00K | 12.20K | 44.60K | 48.60K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.50K | 9.30K | 40.70K | 40.20K | 3.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.70K | 24.80K | -- | -- | 100.50K |
| Total Current Assets | 76.50K | 102.20K | 147.80K | 194.00K | 314.00K |
|
|
|||||
| Total Current Assets | 76.50K | 102.20K | 147.80K | 194.00K | 314.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Other Intangibles | 384.10K | 392.50K | 416.20K | 422.20K | 436.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 2.20K | -- | -- |
| Total Assets | 460.70K | 494.70K | 566.20K | 616.20K | 750.00K |
|
|
|||||
| Total Accounts Payable | 432.50K | 257.20K | 253.80K | 257.80K | 325.20K |
| Total Accrued Expenses | -- | 164.80K | 241.90K | 238.80K | 293.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 959.90K | 937.50K | 1.04M | 978.50K | 1.00M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.39M | 1.36M | 1.53M | 1.48M | 1.62M |
|
|
|||||
| Total Current Liabilities | 1.39M | 1.36M | 1.53M | 1.48M | 1.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.39M | 1.36M | 1.53M | 1.48M | 1.62M |
|
|
|||||
| Common Stock & APIC | 23.66M | 23.62M | 25.20M | 24.85M | 25.07M |
| Retained Earnings | -27.28M | -27.18M | -28.94M | -28.44M | -28.65M |
| Treasury Stock & Other | 2.58M | 2.58M | 2.64M | 2.60M | 2.56M |
| Total Common Equity | -1.03M | -975.30K | -1.09M | -991.80K | -1.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.03M | -975.30K | -1.09M | -991.80K | -1.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 98.80K | 110.50K | 127.40K | 132.80K | 143.80K |
| Total Equity | -931.70K | -864.80K | -967.10K | -858.90K | -872.10K |
|
|
|||||